October 31, 2013
Gary Winer, Vice Chair of PhRMA’s Japan-Based Executive Committee The Pharmaceutical Research and Manufacturers of America, or PhRMA, renewed its call for the permanent introduction of the premium for new drug development, along with other long-standing policy requests, at a...read more